Related Experiment Video
Updated: Aug 9, 2026

Intravital Microscopy of the Mouse Brain Microcirculation using a Closed Cranial Window
Published on: November 18, 2010
Brain capillary blockage produced by a virulent strain of rodent malaria
Abstract:
A sudden enhancement in virulence of a mild Plasmodium berghei yoelii 17 x strain resulted in fulminating and fatal infections in CF1 and A/J mice. The virulent strain has maintained its characteristics after ten cyclical transmissions through Anopheles stephensi. The visible expression of virulence of the mutated strain is its ability to cross the blood-brain barrier and cause intravascular sequestration of injected erythrocytes and blockage of brain capillaries. We, therfore, believe that the virulent line of Plasmodium berghei yoelii 17 x could serve as a useful laboratory model for the study of "cerebral malaria."
Insights
A mild malaria parasite strain became highly virulent, causing fatal brain infections in mice. This virulent strain could be a valuable model for studying cerebral malaria.
Area of Science:
- Malariology
- Infectious Diseases
- Neuroscience
Background:
- Plasmodium berghei yoelii is a rodent malaria parasite.
- Certain strains can cause severe infections.
Purpose of the Study:
- To characterize a newly virulent strain of Plasmodium berghei yoelii.
- To assess its potential as a model for cerebral malaria.
Main Methods:
- Induction of a virulent Plasmodium berghei yoelii 17X strain.
- Cyclical transmission through Anopheles stephensi mosquitoes.
- Infection of CF1 and A/J mice.
Main Results:
- The mutated strain caused fulminating and fatal infections in mice.
- Virulence was maintained over ten transmission cycles.
- The virulent strain crossed the blood-brain barrier, causing capillary blockage.
Conclusions:
- The virulent Plasmodium berghei yoelii 17X strain is a potent model for cerebral malaria research.
- This model allows for studying parasite-induced brain pathology.
Related Concept Videos
Viral Meningitis
Arboviral Encephalitis
Malaria
Bacterial Meningitis II: Pathophysiology

